Drugs / dendritic and cytokine-induced killer cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02886897 | Jul 2016 → Sep 2019 | breast cancer, colorectal cancer, hepatocellular carcinoma, non-small cell lung carcinoma +2 | Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | dendritic and cytokine-induced killer cells | “Autologous dendritic and cytokine-induced killer cells (D-CIK)” NCT02886897 ↗ |
| Known as | D-CIK | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02886897 ↗ |
| Modality | Cell therapy | “Autologous dendritic and cytokine-induced killer cells (D-CIK)” NCT02886897 ↗ |
| Route | Intravenous | “via intravenous infusion” NCT02886897 ↗ |